Overview of trials from AHA 2021.
- Published in:
- Global Cardiology Science & Practice, 2021, v. 2021, n. 4, p. 1, doi. 10.21542/gcsp.2021.29
- By:
- Publication type:
- Article
Works matching AU Nagy, Sherif
Results: 6
1
2
EMPEROR-Preserved: SGLT2 inhibitors breakthrough in the management of heart failure with preserved ejection fraction.
- Published in:
- Global Cardiology Science & Practice, 2021, v. 2021, n. 3, p. 1, doi. 10.21542/gcsp.2021.17
- By:
- Publication type:
- Article
3
Clinical, electrocardiographic, echocardiographic, and angiographic predictors for the final infarct size assessed by cardiac magnetic resonance in acute STEMI patients after primary percutaneous coronary intervention.
- Published in:
- Egyptian Heart Journal, 2024, v. 76, n. 1, p. 1, doi. 10.1186/s43044-024-00526-x
- By:
- Publication type:
- Article
4
A Proposed Digital Platform for Accounting Disclosure about Corporate Social Responsibility.
- Published in:
- International Journal of Management, Accounting & Economics, 2024, v. 11, n. 1, p. 19, doi. 10.5281/zenodo.10808920
- By:
- Publication type:
- Article
5
Once versus twice daily antihypertensive medications for the control of nocturnal blood pressure: a comparative study.
- Published in:
- Egyptian Heart Journal, 2020, v. 72, n. 1, p. 1, doi. 10.1186/s43044-020-00045-5
- By:
- Publication type:
- Article
6
Masked uncontrolled hypertension: Prevalence and predictors.
- Published in:
- Egyptian Heart Journal, 2018, v. 70, n. 4, p. 369, doi. 10.1016/j.ehj.2018.10.001
- By:
- Publication type:
- Article